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INTRODUCTION 
 
Regional anaesthesia is the method chosen for surgeries involving the 
lower abdomen and lower limb in children. It provides a good alternative to 
general anaesthesia. This technique is safe and cost effective in day care 
surgeries. 
The first spinal anaesthesia was performed to August G. Bier by his 
assistant in 1898. This was followed by injection to his assistant Dr.Hildebrant. 
Dr.Bier noted ‘A strong blow with an iron hammer against the tibia was not felt 
as pain’ some twenty three minutes later. 
The first planned spinal anaesthesia was performed by Bier, on 16th 
August 1898, by injection of 0.5% cocaine solution in a patient. 
August Bier first performed the regional anaesthesia techniques in 
children way back in 1899. There are many publications about regional 
anaesthesia in children between 1909 and 1910. Bainbridge operated a three 
month old infant for strangulated hernia under subarachnoid block in 1900. 
Then between 1909 and 1910 there were many reports of about 200 cases of 
surgeries for lower abdomen being taken under subarachnoid block for children 
and infants by a British surgeon called Tyrell Gray.  
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 The regional anaesthetic techniques for children and infants were 
reintroduced later in 1983 by Abajian et al under the American Society of 
Anesthesiologist Regional Anesthesia Breakfast Panel. But due to introduction 
of newer and potent muscle relaxants and volatile anaesthetic agents, the 
paediatric spinal anaesthesia did not become popular. 
In recent years it is on the rise again because of increased awareness and 
knowledge on pharmacology, safe profile of the drugs, availability of dedicated 
equipments for regional anaesthetic techniques and good monitoring in children. 
Thus paediatric subarachnoid block may be the preferred method of anaesthesia 
for surgeries involving the lower abdomen and lower extremity where general 
anaesthesia is contraindicated. 
The most common drugs used for spinal anaesthesia are Lignocaine and 
Bupivacaine. Lignocaine has faster onset and short duration of sensory and 
motor blockade and used for surgeries lasting for less than one and half hours. 
Lignocaine produces sudden and severe hypotension and bradycardia soon after 
block. It also produces transient neurological symptoms in a few patients. 
Bupivacaine produces intermediate to long duration of sensory and motor 
blockade and thus is a good alternative to lignocaine in surgeries of longer 
duration. But the longer duration of motor blockade makes it unsuitable for 
ambulatory surgeries. 
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Ropivacaine provides an alternative to bupivacaine, with lesser duration 
of motor blockade. It has a good hemodynamic stability, with lesser systemic 
toxicity when compared to bupivacaine. 
Hence this study is done to compare the efficacy of Bupivacaine and 
Ropivacaine in spinal anaesthesia in children. 
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AIM OF STUDY 
 
The aim of this study is to evaluate the efficacy of Ropivacaine and 
Bupivacaine in spinal anaesthesia in children posted for infraumblical surgeries. 
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ANATOMY OF SUBARACHNOID SPACE 
Subarachnoid block is a type of central neuraxial blockade, where 
temporary interruption of nerve transmission with in subarachnoid space is 
produced by injection of local anaesthetic solution into cerebrospinal fluid. 
Applied anatomy 
The vertebral column comprises of 33 vertebrae – 
 Cervical  7 
 Thoracic 12 
 Lumbar 5 
 Sacral 5 
 Coccygeal 4 
Vertebral column has four curves 
 Cervical and Lumbar  -  convex anteriorly 
 Thoracic and Sacral - convex posteriorly 
Each vertebra is composed of a body, pedicle and laminae and separated by 
intervertebral disc. The vertebral column is bound by ligaments.  
 
 ANATOMY OF SPINAL CORD 
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The structures which are pierced while performing lumbar puncture are 
 Skin 
 Subcutaneous tissue 
 Supraspinous ligament – connecting the tips of spinous process 
 Interspinous ligament  – joins the spinous process together 
 Ligamentum flavum   – running from lamina to lamina – yellow ligament 
 Duramater 
 Arachnoid membrane 
Spinal cord 
   In adults it extends from medulla oblongata above to the upper border of 
first lumbar vertebrae below. It terminates as cauda equina, a leash of nerve 
roots. 
There are 31 pairs of spinal nerves as follows 
  Cervical - 8 
  Thoracic - 12 
  Lumbar  - 5 
  Sacral   - 5 
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  Coccygeal - 1 
 The spinal nerves are composed of anterior and posterior roots which 
unite in the inter vertebral foramina and form a nerve trunk. The dural sac 
extends upto the level of S2 in adults. 
The coverings of spinal cord are  
 Piamater 
 Arachnoid membrane 
 Duramater 
Blood supply: 
 It is from one anterior spinal artery, a branch of vertebral artery and a pair 
of posterior spinal arteries arising from the posterior inferior cerebellar arteries. 
Spinal cord also receives additional blood supply from the intercostal arteries 
arising in the thoracic level and lumbar arteries arising in the lumbar level. The 
largest of the radicular arteries is called ‘artery of Adamkiewicz’. 
 The spinal veins are formed by anterior and posterior plexuses. These 
plexuses drain into vertebral, azygous and lumbar veins. 
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Cerebrospinal fluid 
 CSF is an ultrafiltrate of the blood plasma. It is formed from choroid 
plexus of the lateral ventricles. It is a clear, colourless fluid. The total volume of 
CSF is 120- 150ml. It is distributed between the ventricles of brain, cranial and 
spinal subarachnoid spaces. 
Composition of CSF:  
Specific gravity 1.006  
Pressure 60-80mm H2O 
PCO2 48mmHg 
Na+ 133-145 meq/l 
Cl- 15-20 mg/dl 
Ca2+ 2-3 meq/l 
Mg+ 2-2.5 mg/dl 
PO4- 1.6 mg/dl 
Sugar 45-80 mg/dl 
Protein 23-28 mg/dl 
Lymphocytes 0-5 cells/cu.mm 
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Baricity: 
Baricity of local anaesthetic drug is measured by a ratio of the density of 
local anaesthetic to the density of CSF at 37o C. The baricity determines the 
spread of local anaesthetic solution in spinal subarachnoid space. Local 
anaesthetic can be isobaric, hypobaric or hyperbaric depending on the baricity 
of solution. 
Hyperbaric   -  > 1.008gm/ml 
Isobaric  - 0.998 – 1.008 
Hypobaric -  < 0.998 
 Density Baricity 
Water 0.9933 0.9933 
CSF 1.0003 1.0000 
Isobaric   
Lignocaine 2% 1.0004 1.0003 
Bupivacaine 0.5% 0.9993 0.9990 
Ropivacaine 0.5% 0.9995 0.9988 
Hyperbaric   
Lignocaine 2% in dextrose 7.5% 1.0265 1.0265 
Bupivacaine 0.5% in dextrose 8% 1.0210 1.0207 
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Hypobaric solutions being less dense than CSF rise against gravity and it 
leads to higher spread. Isobaric solutions being as dense as CSF  remain at the 
level of injection. The cephalad movement is due to bulk movement of CSF in 
subarachnoid space. Hyperbaric solutions being denser than CSF follow gravity 
after injection. Thus the spread of drug is influenced by positioning after 
performing the subarachnoid block. 
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PHYSIOLOGY OF SUBARACHNOID BLOCK 
Subarachnoid block is a temporary and reversible interruption of nerve 
transmission from the spinal cord by injecting local anaesthetics in 
subarachnoid space.  
Factors influencing the height of blockade are 
a. Site of injection 
b. Angulation of needle 
c. Barictiy of local anaesthetics 
d. Dose of local anaesthetics 
e. Position of patient during and after injection 
f. Anatomic configuration of  spinal  column 
g. Patient height (at extremes) 
h. Volume of cerebrospinal fluid 
i. Reduced CSF with increased intra abdominal pressure (eg. pregnancy) 
Factors not influencing block height are 
a. Weight of patient 
b. Gender 
c. Needle type  
d. Rate of injection 
e. Barbotage 
12 
 
f. Coughing and straining during injection 
g. Vasoconstrictor addition 
Effect on Cardiovascular system 
 The effect on cardiovascular system depends on various factors like the 
level of sympathetic blockade, hydration of the patient, and effect of vagal 
innervations. The most prominent effect is that of bradycardia and hypotension.  
 The factors producing hypotension in subarachnoid block are 
a. Peripheral sympathetic blockade of T10-L2 fibers which leads to 
dilatation of post arteriolar capillaries and venodilatation. It produces 
increased venous capacitance, pooling of blood in lower extremities 
and decrease in venous return.  
b. Adrenal medullary sympathetic block of T6-L1 level causes blockade 
of splanchnic nerves and pooling of blood in gut. Further it decreases 
the release of catecholamines which lead to decrease in heart rate and 
cardiac output. 
c. Supine hypotension syndrome produced by compression of inferior 
vena cava and aorta by pregnant uterus or abdominal tumours. 
d. Direct inhibition of cardioaccelerator fibers T1-T4 in case of high 
spinal. 
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The reflexes producing bradycardia in subarachnoid block are 
a. BAINBRIDGE REFLEX: the cardio accelerator fibers get less 
efferent outflow due the decrease in venous return. 
b.  SINOATRIAL NODE STRETCH REFLEX : stretch receptors in  the 
SA node respond proportionally to venous return 
c. BEZOLD JARISCH REFLEX: stretching baroreceptors in 
inferoposterior wall of LV respond to increases in ventricular 
contractilty induced by reductions in preload and ventricular volume. 
Stretching baroreceptors paradoxically increase vagal output from 
vasomotor centre. 
Effect on Nervous system 
The Site of action is spinal nerve roots and it produces differential neural 
blockade as nerve fibres subserving different functions display varying 
sensitivity to local anesthetics. The order of blockade of fibers is autonomic 
fibers first followed by pain, temperature, touch, proprioception and skeletal 
muscle tone.  
In subarachnoid block, the level of autonomic block is two segments 
higher than the level of sensory block, which are again two segments higher 
than the level of motor block. This type of block is called as differential 
blocakade. The segments where there is one type of block without others are 
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called as zones of differential blockade. The zones of differential blockade are 
produced due to various factors like, different diameter of axons, the number of 
nodes blocked, decremental conduction in nerve fibers and time available for 
diffusion. The local anaesthetic agents also have different affinity for different 
types of axons. This zone of differential blockade remains constant in extent 
during maintenance and regression of the level of anaesthesia when it wears off. 
Effects on Respiratory system 
 There is no apparent effect on respiratory system when the block is 
maintained upto T4 level. The tidal volume, respiratory rate, minute ventilation 
and arterial oxygenation are well maintained. But in COPD patients there is 
decrease in these volumes as the intercostals are paralysed.  
Apnea after spinal anaesthesia is due to following reasons 
a. Medullary ischemia due to hypotension produced by subarachnoid 
block 
b. High spinal blocking the C3,4,5 – phrenic nerves 
Effect on GIT 
 Sympathetic blockade and parasympathetic over activity causes 
contracted gut with relaxed sphincters and thus increasing peristalsis. Nausea 
and vomiting is produced due to central hypoxia caused by hypotension. There 
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may be discomfort due to handling of viscera which also causes 
parasympathetic activation. 
Effect of Liver and Kidneys 
 The hepatic blood flow is determined by blood pressure but maintained 
by hepatic arterial buffer system. The hepatic oxygen extraction is normal. The 
autoregulation in kidneys maintain the blood flow until the mean arterial 
pressure of 50mmHg. 
Effect on Genitourinary system 
 The tone of ureter and bladder is not changed and sphincters are not 
relaxed. But urinary retention occurs in many patients. The penis is engorged 
due to venodilation. The tone of pregnant uterus is unchanged. There is no 
effect on uterine blood flow and progress of labour. 
Metabolic and hormonal effect 
 It inhibits the stress response and decreases the release of blood sugar, 
cortisol, renin and aldosterone. It blocks the responses of nociceptive stimuli. 
Antidiuretic hormone release is also inhibited. 
Thermoregulation 
 The vasodilatation produced by subarachnoid block causes hypothermia 
due to heat loss to cold environment. 
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VARIATIONS OF SUBARACHNOID BLOCK IN CHILDREN 
Anatomy 
 The knowledge of anatomical differences in spinal cord in children helps 
us to provide safe and efficient spinal anaesthesia in children. The major 
differences are 
a. The spinal cord terminates at level of lower border of L3 when 
compared to lower border of L1 in adults – so subarachnoid block is 
given at a lower space of L4-5 than L3-4 used in adults 
b. The Tuffier’s line joining the highest point of both iliac crest crosses 
at level of L4-5 or L5-S1 than that of adults where it crosses between 
L3-4 interspace. 
c. The dural sac ends at level of S2 in adults and S4 in neonates – leads 
to more chances of injury. 
Pharmacokinetics 
Local anesthetic drugs are bound to a type of plasma protein called as α-1 
acid glycoprotein (AAG). Children have lesser amount of plasma proteins. The 
plasma level is just 20% to 40% to that found in adults. The normal levels are 
obtained by a about 1 year. Thus the free fraction of local anaesthetic drug is 
higher due to low levels of α-1 acid glycoprotein. The higher level of unbound 
drug causes toxicity. Children have less clearance and increased elimination 
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time for local anaesthetics. These factors contribute to the increased risk of local 
anesthetic toxicity because of free drug circulating in plasma during regional 
techniques. 
Developmental Differences 
 The myelination of nervous system is not fully developed until about 12 
years of age. This incomplete myelination of nervous system leads to more 
penetration of local anaesthetic drug into nerve roots. The loose attachment of 
facial tissues around the nervous system also facilitates the uptake of local 
anaesthetic drug. Thus less amount of local anaesthetic drug can produce full 
block in children compared to adult and the level of block may also be more.  
The local anaesthetic drug as wears off more faster in children due to increased 
spread.  
Cerebrospinal Fluid Volume 
Cerebrospinal Fluid volume varies according to the patient age which 
bears considerable pharmacokinetic relations to drug used. The volume of 
cerebrospinal fluid in different age group is as follows 
 Neonates - 10ml/kg 
 Infants - 4ml/kg 
 Children - 3ml/kg 
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 Adults - 1.5 to 2 ml/kg 
The distribution of Cerebrospinal fluid between the cerebral and spinal 
circulation also varies with age. Children have about 50% of volume in spinal 
subarachnoid space compared to adults who have only 25% of total volume in 
spinal subarachnoid space. Thus larger volume of local anaesthetic drugs is 
needed for infants and children. Also the Cerebrospinal fluid hydrostatic 
pressure is lower in infants in the dorsal recumbent position. Thus progression 
of the needle during subarachnoid block must be slow to detect Cerebrospinal 
fluid reflux before the needle is advanced too far. 
Hemodynamic effects 
 The incidence of hypotension and bradycardia following subarachnoid 
block is less due to poor development of sympathetic systems in neonates and 
children. But children more than 5 years of age may have similar effects to that 
of adults. 
Post dural puncture headache 
 The incidence of headache following subarachnoid block is much less in 
children and the use of smaller and finer gauge needle may further decrease the 
incidence. 
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Post operative apnoea 
 The regional anaesthesia technique does not decrease the occurence of 
apnoea in post operative period in neonates, though much lesser than that of 
general anaesthesia. The use of sedatives like ketamine during regional 
anaesthesia may increase the incidence of postoperative apnoea. 
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PHARMACOLOGY OF BUPIVACAINE 
 
 Bupivacaine is the amino amide local anaesthetic.  
 It is a derivative of Mepivacaine. The butyl group replaces the methyl 
group in the piperidine chain. 
 Bupivacaine was first synthesized by Ekenstem. 
 It was first used by Telivuo in 1963 
 Bupivacaine is available as a raecemic mixture. 
 Being a very stable compound , it can be autoclaved many times 
 
PHYSICO CHEMICAL PROPERTIES 
 Chemically described as d(1)-1-butyl-N-(2’6’ dimethylphenyl) piperidine 
– 2- carboxamide.  
 
 
 
 
1. Molecular Weight : 288 (base) 
2. Pka  : 8.1 
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3. Protein binding : 95.6% 
4. Plasma protein binding : 2 μgm/ml 
5. Lipid solubility : 28 
6. Partition coefficient : 27.5 (n-Haptane pH7.4 buffer) 
7.  Approximate anaesthetic duration : 175minutes 
8.  Elimination half life : 210 minutes 
9. Toxic plasma concentration : more than 1.5microgram/ml 
 
PHARMACOKINETIC PROPERTIES 
Absorption 
 The plasma level of drug depends on the route and site of absorption. 
Also the richness of vessels at the site and presence of vasoconstrictors 
determine the rate of absorption. From the intrathecal route the drug is absorbed 
by nerve rootlets. Bupivacaine has higher lipid solubility and thus it easily 
penetrates the nervous and vascular tissues. 
Distribution 
 About 80-95% of the total drug is bound to plasma protein especially 
alpha-1-acid glycoprotein. It has got a bimodal distribution phase containing a 
rapid distribution phase and slow distribution phase. In the rapid distribution 
phase the drug is first distributed to vascular tissues with a half life of about 2.7 
minutes. Later in the slow distribution phase the drug is distributed to all tissues 
with a half life of about 28 minutes. The total half life involving the 
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biotransformation and excretion is about 3.5hours and the plasma clearance is 
about 0.47liters/minute. 
 
Metabolism  
The metabolism of bupivacaine takes place in liver. The metabolism  
begins with hydroxylation of the aromatic ring and removal of piperidine side 
chain. Thus it forms pipecolyxylidine derivatives. It is one eighth as toxic as 
bupivacaine and both compounds are excreted in urine. It also forms a more 
conjugated water soluble metabolite N-desbutyl bupivacaine. The conjugated 
form is freely excreted in urine. Bupivacaine undergoes extensive pulmonary 
extraction. The pulmonary extraction is inhibited by propranolol. 
 
Elimination 
 Most of the drug and metabolites are excreted through the kidneys. 4 to 
10% of the drug is excreted in unchanged form. The plasma clearance is about 
0.47liters/minute. 
 
Mechanism of action 
 Bupivacaine acts through the sodium channel blockade.  It produces a 
non-depolarising type of blockade. It interferes with the transmembrane sodium 
channel thereby interfere with sodium ion transport. This delays the 
depolarization process and the channel remains in a state of persistent 
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repolarization. The drug probably acts at the level of nerve rootlets in the spinal 
cord, fine nerve filaments and the lateral and posterior part of spinal cord. 
 
PHARMACODYNAMIC PROPERTIES 
Effect on nervous system 
 Bupivacaine acts on both the A δ and C fibers. The higher lipid solubility 
of bupivacaine makes it fast acting and longer duration of block compared to 
ropivacaine. It causes profound motor block in high concentration. In low 
concentration it spares the motor fibers and produces sensory blockade. This 
property is useful for post operative analgesia. But the effect of motor blockade 
is more than that of ropivacaine. The addition of epinephrine does not alter the 
intensity or duration of block. 
 It causes both excitation and inhibition of the central nervous system. The 
toxic effects are manifested as tremors, convulsions, respiratory arrest and 
coma. 
 
Effect of Cardiovascular system 
It depends on the level of sympathetic blockade and number of segments 
blocked. It produces bradycardia and hypotension due to sympathetic blockade. 
High spinal block inhibits the cardio acceleratory fibers and produce cardiac 
arrest. The cardiotoxicity of bupivacaine is more than that of lignocaine. As 
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bupivacaine is more lipid soluble, it has more affinity towards myocardial 
fibers. Bupivacaine is a potent myocardial depressant. This effect is exacerbated 
with hypoxia, hypercarbia and by pregnancy. Ventricular arrythmias and 
fibrillation occur in toxic doses and are resistant to revival with bretyllium. 
Convulsions occur with plasma concentration of about 5.4microgram/ml. 
 
Effect on respiratory system 
 There is no apparent change in respiratory function in normal doses. The 
tidal volume, respiratory rate and minute volume are maintained. In high 
spinals, it produces respiratory depression due to paralysis of intercostals and 
diaphragm. 
 
Indications: 
 
Surgical anaesthesia: 
 Spinal anaesthesia 
 Epidural anaesthesia 
 Caudal anaesthesia 
 Peripheral nerve block and infiltration anaesthesia 
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Pain management: 
 Labour analgesia – intermittent bolus or continous infusion  
 Post  operative  pain management – epidural infusion as 
o Intermittent bolus 
o Continous infusion 
o Patient controlled analgesia 
Management of pain in children: 
 Caudal anaesthesia 
 Peripheral nerve blocks and infiltration anaesthesia. 
Contraindications: 
1. Known cases of allergic reactions to amide type of local anaesthetics 
2. Intravenous regional anaesthesia (Bier’s block).  
3. Hemodynamic instability 
4. Septicemia 
5. Local site infection 
Adverse effects 
The adverse reactions to bupivacaine are related to excessive plasma 
levels which are caused by over dosage of drug used, unintentional intravascular 
injection and slow metabolic degradation of drug. The maximum effective dose 
(c max) is 0.7μgm/ml. The signs of toxicity begin to appear with doses of about 
1.6μgm/ml. The toxicity ratio of Bupivacaine is about (c tox/c max) 2.3.  
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The various side effects produced are 
 Central and peripheral nervous System – dyskinesia, hypokinesia, 
neuropathy, vertigo, tremors, paresis, neuropathy and coma. Convulsions 
are produced due to toxic level of drugs.   
 Cardiovascular System – bradycardia , hypotension, vasovagal reaction, 
syncope, arrythmias, ventricular fibrillation 
 Gastrointestinal System - nausea and vomiting, incontinence, tenesmus. 
 Hearing and Vestibular - tinnitus, hearing abnormalities.  
 Hepato - Biliary System – jaundice  
 Musculoskeletal System – myalgia.  
 Psychiatric Disorders - insomnia, confusion, amnesia, hallucination, 
nightmares. 
 Urinary System Disorders- urinary incontinence. 
 Skin Disorders - urticaria. 
 Vascular - deep vein thrombosis, phlebitis, pulmonary embolism. 
 
Availability 
Bupivacaine is available in concentration of 0.25% and 0.5% solutions. It 
is available both as isobaric and hyperbaric solution. Hyperbaric solution is 
prepared by adding dextrose to the local anaesthetic solution. It is available in 
ampoules of 0.5% preservative free for spinal anaesthesia. It is available in vials 
of 0.25% and 0.5% with preservative for epidural and nerve blocks 
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Dosages 
 Spinal - 3 to 4 ml of 0.5% solution for adults 
   0.3 to 0.5mg/kg of 0.5% solution for children  
 Epidural - 15 to 20 ml of 0.5% or 0.25% solution 
   0.125% solution produces sensory block only 
 Caudal - 0.5ml/kg of 0.25% solution for sacral block 
   0.75ml/kg of 0.25% solution for lumbar block 
   1ml/kg of 0.25% solution for thoracic block 
 Peripheral nerve blocks – 15 to 20 ml of 0.25% solution 
The toxic level is reached when more than 2mg/kg of drug volume is used.  
 
 
 
 
 
 
 
 
 
 
 
 3 D structure of Bupivacaine 
 
 
3 D structure of Ropivcaine 
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PHARMACOLOGY OF ROPIVACAINE 
 
 Ropivacaine is the new amino amide local anaesthetic. It is a derivative 
of pipecoloxylidide. 
 Pipecoloxylidide was first synthesized in 1957. 
 Pipecoloxylidide are chiral drugs due to asymmetric carbon atoms and 
form two groups of S and R enantiomers. 
 Ropivacaine is a pure S enantiomer with chiral purity of 99.5% 
 Ropivacaine is prepared by alkylation of S enantiomer of dibenzoy-l-
tartaric acid 
Physiochemical properties: 
Chemically defined as S-(-)-1-propyl-2',6’-pipecoloxylidide 
hydrochloride monohydrate 
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1. Molecular wt - 274 
2. Pka   -  8.07 
3.  pH   -  7.4 
4. Protein binding -  94% 
5. Partition coefficient (lipid solubility)  -  8.7 
It denotes the N heptanes buffer. This property of lower lipid 
solubility produces delayed and less binding to A delta fibers and less 
motor blockade. 
6. Mean uptake ratio - 94 
7. T1/2       -  111 minutes 
8.  Clearance      - 10.3 L/minutes. 
 
MECHANISM OF ACTION 
Ropivacaine acts through inhibition of sodium channel. It inhibits the 
conduction of sodium ions through the channel and also potassium channel. 
Thus it inhibits the production and conduction of impulses across the nerve 
fibers. This type of block is reversible.  
PHARMACOKINETIC PROPERTIES: 
Absorption 
The plasma concentration of ropivacaine is dependent on many factors 
like route by which it is given, dose of drug administered, concentration of drug 
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used, vascularity of the region and hemodynamic status of patient. It shows the 
biphasic absorption phase from the epidural space. The mean half life is 14 
minutes in first phase and 4 hours in second phase. The rate limiting factor is 
the slow absorption from the epidural phase. Thus it has longer duration of 
action through the epidural route.  
Distribution 
The steady state plasma concentration after intravascular injection is 
about 59+7 liters in total volume of distribution. The protein bound fraction is 
about 94%. It mainly binds to α–1- acid glycoprotein. There is an increase in 
bound form of drug in post operative state due to increase in α-1-acid 
glycoprotein from stress response in surgery. This is especially so after 
continuous epidural infusion. Ropivacaine can easily cross the placenta and 
equilibrium is reached. 
Metabolism 
 Most of the metabolism of ropivacaine occurs in liver. It is mainly 
metabolised by aromatic hydroxylation involving cytochrome P4501A to 3-
hydroxy ropivacaine. About 37% of the total dose is excreted in urine. It is 
excreted in both free and conjugated form of 3-hydroxy ropivacaine. There is a 
low concentration of 3-hydroxy ropivacaine in the plasma. Another metabolite, 
2-hydroxymethyl- ropivacaine has been identified but is not quantified in the 
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urine. 3-OH-ropivacaine and N-de-alkylated metabolite of ropivacaine are the 
major metabolites excreted in the urine. These are especially formed during the 
continous epidural infusion. There is no raecemerization between the S and R 
forms in the body.  
Elimination 
 Ropivacaine is mainly eliminated through the kidney as various 
metabolites.  Some about 86% of the total drug is excreted through the kidneys. 
The total clearance is about 387 ml/min. The mean half life is about 1.8 hours 
after intravascular injection and about 4.2 hours after epidural injection. 
PHARMACODYNAMIC PROPERTIES: 
Action on Nervous system 
 The type of blockade produced by ropivacaine depends upon the 
concentration of drug used. In low concentration it blocks both Aδ and C fibers 
which is more potent than that of equal concentration of bupivacaine. In high 
concentration, the blockade of Aδ fibers is less than that of bupivacaine while 
the blockade of C fibers is similar. The penetration of ropivacaine into myelin 
sheath is less due to low lipid solubility compared to bupivacaine. Thus it 
preferentially blocks C fibers than Aδ fibers. This causes less potent motor 
blockade.   
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 The addition of epinephrine does not influence the type of blockade 
produced. In toxic doses, it causes initial excitation of nervous system 
manifesting as restlessness, tremor, and convulsions. Later it leads to depression 
of medullary centre and coma. 
 Effect on Cardiovascular system 
 The effects are mostly due to blockade of sympathetic fibers. There is 
decreased venous return and decreased heart rate which produces hypotension. 
Effect on respiratory system 
 Ropivacaine does not have any marked effect on the respiratory system in 
normal doses. Higher doses leading to toxicity of drug produces respiratory 
depression secondary to medullary depressant effect. 
 
INDICATIONS 
Surgical anaesthesia: 
 Spinal anaesthesia 
 Epidural anaesthesia 
 Caudal anaesthesia 
 Peripheral nerve block and infiltration anaesthesia 
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Pain management: 
 Labour analgesia – intermittent bolus or continous infusion  
more in  walking epidurals 
 Post  operative  pain management – epidural infusion as 
o Intermittent bolus 
o Continous infusion 
o Patient controlled analgesia 
Management of pain in children: 
 Caudal anaesthesia 
 Peripheral nerve blocks and infiltration anaesthesia. 
CONTRAINDICATIONS 
1. Known cases of allergic reactions to amide type of local anaesthetics 
2. Intravenous regional anaesthesia (Bier’s block).  
3. Obstetric Para cervical anaesthesia.  
4. Hemodynamic instability 
5. Septicemia 
6. Local site infection 
Adverse effects 
The adverse reactions to ropivacaine are related to excessive plasma 
levels due to excess dosage, inadvertent intravascular injection and slow 
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metabolic degradation. The mean doses of plasma level when toxicity begin to 
occur are  about  4.3 and 0.6 μg/ ml of total and free plasma concentrations 
respectively. The toxic levels are reached in cases of continuous epidural 
infusion as the drug is administered for long times.  
The various possible side effects are: 
 Cardiovascular System – bradycardia, hypotension, vasovagal reaction, 
syncope, arrhythmias. Due to low lipid solubility the cardiotoxic potential 
is less than that seen with bupivacaine. 
 Central and peripheral nervous System – dyskinesia, hypokinesia, 
neuropathy, vertigo, tremors, paresis and coma  
 Gastrointestinal System - nausea and vomiting, incontinence, tenesmus 
 Hearing and Vestibular - tinnitus, hearing abnormalities  
 Hepato - Biliary System – jaundice  
 Musculoskeletal System – myalgia  
 Psychiatric Disorders - insomnia, confusion, amnesia, hallucination, 
nightmares 
 Urinary System Disorders- urinary incontinence 
 Skin Disorders - urticaria 
 Vascular - deep vein thrombosis, phlebitis, pulmonary embolism. 
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Availability 
 Ropivacaine is available in ampoules of isobaric solution in concentration 
of 0.2%, 0.5% and 0.75%. The solutions are prepared in preservative free form. 
 
Dosages 
 Spinal -   3 to 4ml of 0.5% or 0.75% in adults 
        0.3 to 0.5mg/kg of 0.5% solution in children 
Epidural - 15 to 20 ml of 0.2% or 0.5% solution 
 Caudal   -  1ml/kg of 0.2% solution  
 Peripheral nerve block – 15 to 30 ml of 0.15% to 0.5% 
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MECHANISM OF ACTION OF LOCAL ANAESTHETICS 
The local anaesthetics inhibit the conduction of impulses across the 
nerves by the following mechanism as defined by Carvino 
The local anaesthetic drug exists in both charged and uncharged forms. 
The relative concentrations of the two forms are dependent on the pKa of the 
solution, pH of the site where injected. The positively charged cation form is the 
active form. It produces local anaesthetic action. 
 The uncharged base form is responsible for the diffusion across the 
liphophilic membranes across the cell. The drug acts from the inside of the cells 
on sodium ion channel. They occupy specific receptors on the inner side of 
sodium channel and inhibit the conduction of ions through them. Thus the cell 
remains in a state of persistent depolarization. This inhibits the propogation of 
action potential. 
Other probable site of actions are 
 Channel narrowing and membrane expansion due to nonspecific 
absorption across the cell membrane 
Unchanged base form diffuses across hydrophobic pathways of lipid 
membranes to reach specific receptor sites and protonation of drug to bind to 
inner opening of sodium channel. 
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The surface charge theory:  
This theory is based on penetration of the axonal membrane by lipophilic 
portion of the local anaesthetic drug and neutralisation of axolemmal negative 
charges on surface by the positively charged terminal amino group of drug.  The 
electronegativity of the external membrane is counteracted by the acquired 
positive charges. This results in increase in the transmembrane potential without 
altering much of the intracellular resting potential. This inhibits the conduction 
of nerve impulses from the normal areas to anaesthetized areas of the nerve 
membrane. Thus it produces a conduction block across the two portions. 
According to surface charge theory the active form of local anaesthetic drug is 
the charged form of drug. 
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This study was conducted in 93 children aged 1 – 17 years 
scheduled for infraumblical surgeries. The children were divided into 
three groups of preschool age children (1-4yrs), school age children (5-
11yrs) and adolescents (12-17yrs). All children were given Isobaric 
ropivacaine 0.5mg/kg in spinal anaesthesia. The parameters monitored 
were height of sensory block, regression of block by two segments, 
regression of block to T10, duration of sensory and motor block, rescue 
analgesia and time to discharge from PACU. Average height of block was 
T6- T8, 2 segment regression 40-130 min, regression of block to T10 was 
90 min in average, the time of first recue analgesia was 130 min in 
average, time to discharge was 200 min in average. The mean height of 
block was lower in older children but the duration of sensory block was 
similar. Motor block developed with ropivacaine were less profound than 
that of bupivacaine and greater degree of separation of motor and sensory 
block was seen.  Thus ropivacaine can be alternative to bupivacaine for 
spinal anaesthesia in children. 
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2. Acta Anesthesiologica Belgia 2008, Vol.59, Pages 65 -71  
Mantouvalou, S.Kalli and colleagues 
Compared the spinal characterics of spinal anaesthesia with 15mg 
of isobaric Ropivacaine, Bupivacaine, and Levobupivacaine for about 
120 patients posted for lower abdominal surgeries. Ropivacaine had a 
delayed onset with less duration of sensory and motor blockade compared 
to bupivacaine and levobupivacaine. Bupivacaine group had a higher 
incidence of hypotension than both. 
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V.Gupta , A.Metha, and colleagues 
Comparison of 15mg of isobaric bupivacaine, levobupivacaine and 
ropivacaine for spinal anaesthesia in patients posted for lower limb 
surgeries. The onset of sensory block was 4 minutes with bupivacaine and 
5 minutes with ropivacaine. The onset of motor block was 5.5 minutes 
with bupivacaine compared to 6.5 minutes with ropivacaine. The 
ropivacaine group had a delayed onset of motor and sensory block than 
bupivacaine group. The average duration of sensory block was 140 
minutes with ropivacaine group compared to 170 minutes with 
bupivacaine. The average duration of motor block was 130 minutes with 
ropivacaine compared to 170 minutes with bupivacaine. Thus recovery 
from motor and sensory block was faster in ropivacaine group. The 
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hemodynamic stability was better in ropivacaine group. Thus it was 
concluded that ropivacaine group produced spinal blockade of shorter 
duration with better hemodynamic stability and early ambulation of the 
patients than other groups. 
 
4. Acta anaesthesiol Scandinavia 2011,  
E. Marret, A. Thevinin et al  
This study compared between 0.5% bupivacaine and 0.5% 
ropivacaine in spinal anaesthesia for varicose vein stripping. The patients 
were allocated into spinal bupivacaine 10mg group and ropivacaine 10mg 
group with and without sufentanyl. The mean duration of sensory block 
was 68 minutes and 150 minutes with ropivacaine and bupivacaine 
respectively. The mean duration of motor block was 90 minutes and 180 
minutes with ropivacaine and bupivacaine respectively. Thus ropivacaine 
had shorter duration of sensory and motor blockade. With this shorter 
duration of blockade ropivacaine is most suitable for ambulatory 
surgeries. 
 
5. Journal of clinical anaesthesiology 2006, Vol.18,  pages 521 – 525 
Neval Boztuz MD and collegues at turkey. 
Comparision between 15mg of isobaric ropivacaine and 7.5mg of 
isobaric bupivacaine in spinal anaesthesia for patients undergoing 
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ambulatory arthroscopic surgeries. The ropivacaine group had a delayed 
onset of motor and sensory block with faster recovery from the block. 
The level of maximum sensory block reached was less in ropivacaine 
group. 
6. British Journal of Anaesthesia 2009, Vol.103, Pages 731-738 
G.Frowley, R.K.Smith, P.Ingelmo 
This study was conducted to compare the relative potency of 
ropivacaine, bupivacaine and levobupivacaine by minimum local 
anaesthetic concentration model. The ED50 and ED95 of each drug were 
determined by means of two phases of study. The phase I study involved 
a up-down sequential allocation model. The patient first received about 
0.25ml/kg of  drug first and further doses increased or decreased by 
0.025ml/kg depending on the success or failure of the case. The minimum 
local anaesthetic concentration ED50 was determined by means of more 
than six positive or negative deflections. The phase II study involved dose 
escalation. The drug doses selected were 0.05ml/kg above ED50 doses. 
Dose response curve were plotted to derive ED95. The ED50 of 
bupivacaine, levobupivacaine and ropivacaine were 0.3mg/kg, 0.55mg/kg 
and 0.5mg/kg respectively. The ED95 of bupivacaine, levobupivacaine, 
and ropivacaine were 0.96mg/kg, 1.18mg/kg and 0.99mg/kg respectively. 
Thus ropivacaine had shorter duration of action than bupivacaine 
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7. Anaesthesiology 1999, vol.91, pages 1239 - 45 
Gautier PE, DE kock, Van steenberge A et al,Belgium 
Comparison of various doses of isobaric ropivacaine and 
bupivacaine in spinal anaesthesia for patients posted for various 
ambulatory surgeries. The doses compared are isobaric bupivacaine 8mg, 
isobaric ropivacaine 8mg, ropivacaine 10mg, ropivacaine 12mg and 
ropivacaine 14mg.  The onset, offset and duration of sensory and motor 
block are studied. It was concluded that 12 mg of ropivacaine is 
equivalent to about 8 mg of bupivacaine. 
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Mc Namee D , Mc Clelland, A.M., and colleagues  
Comparison of isobaric ropivacaine 0.5% with bupivacaine 0.5% 
in spinal anaesthesia for patients posted for total hip arthroplasty. The 
onset of motor and sensory block was found to be equal of about 2 
minutes. The duration of sensory blockade at T10 level was 3 hours in 
ropivacaine group and 3.4 hours in bupivacaine group. The duration of 
motor blockade was about 2.1 hours in ropivacaine group compared to 
3.9 hours in bupivacaine group. The hemodynamic stability was 
comparable in both groups. Ropivacaine group had shorter duration of 
sensory and motor blockade than bupivacaine group.   Thus ropivacaine 
can be better alternative to bupivacaine in ambulatory surgeries. 
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bupivacaine in spinal anaesthesia for patients posted for TURP or TURB. 
The maximum height of senory block achieved was T7 with bupivacaine 
and T9 with ropivacaine. The hemodynamic stability was comparable in 
both groups. But there was less analgesia in ropivacaine group. 
 
10. Indian journal of anaesthesia 2006, Vol.46, Pages 445-448 
Dr.Anup Gogia, Dr.Ameeta sahni, Dr. Rama Nason, Dr. Rupa 
Comparison between hypobaric, isobaric and hyperbaric forms of 
bupivacaine in spinal anaesthesia for patients posted for total knee 
arthroplasty. The maximum level of sensory blockade achieved was 
higher in hyperbaric than hypobaric or isobaric groups. 
 
11. British journal of anaesthesia, 2001, vol.87, Pages 743 – 747 
A.M.Clelland , Mc Nanee, L.Parts   
Comparison of various dosages of isobaric ropivacaine in spinal 
anaesthesia for patients posted for total hip arthroplasty. The doses 
selected were isobaric ropivacaine 0.75% and 1%. The onset of sensory 
block was 2 minutes in both groups. The median duration of sensory 
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block was longer in 1% of about 3.4hours compared to 3 hours in 0.75% 
group. The duration of motor block was significantly longer in 1% group 
when compared to 0.75% group. 
 
12. Anaesthesia and Analgesia 2009, Vol.109, No.4, Pages 1331-1334 
Ying Y.Lee, Warwick D Nang, Siu Y.Fong et al 
This study was conducted to determine the median effective dose 
of bupivacaine, levobupivacaine and ropivacaine for lower limb 
surgeries. 75 patients were divided into three groups and dose of each 
drug was changed with up-down scale model. The initial dose was taken 
as 8mg and further drug dose was increased or decreased by 1mg 
depending on the failure and success of block. Success was defined as 
bilateral sensory block of about 20min at T10 dermatome. The ED50 of 
bupivacaine, levobupivacaine and ropivacaine were 5.5mg, 5.6mg and 
8.4mg respectively. Thus ropivacaine produce shorter duration of sensory 
and motor block than bupivacaine or levobupivacaine. 
 
13. Anaesthesia and analgesia 2005, Vol.101, Pages 77-82 
Gianleuca Capellari MD, Georgio Aldehri MD, Georgio et al 
This study was conducted to compare hyperbaric levobupivacaine 
and ropivacaine for knee arthroscopic surgery under subarachnoid block 
in day care setup. The patients were divided into three groups of 7.5mg of 
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0.5% ropivacaine, 5mg of 0.5% levobupivacaine and 7.5mg of 0.5% 
levobupivacaine in spinal anaesthesia. The time for complete resolution 
of block and fitness for home discharge were noted. The average time for 
complete resolution of block was 135 minutes with ropivacaine, which 
was shorter than 150 minutes in 5mg levobupivacaine or 160 minutes in 
7.5mg levobupivacaine group. The average time to discharge was 197 
minutes in ropivacaine group compared to 230minutes in levobupivacaine 
group. Thus ropivacaine is advantageous in ambulatory setup. 
 
14. British Journal of Anaesthesia 2003, Vol.90, Pages 304-308 
J.B.Whiteside, J.A.W.Wildsmith and D.Burke 
This study was done to compare the hyperbaric ropivacaine 0.5% 
and hyperbaric bupivacaine 0.5% for spinal anaesthesia in elective lower 
abdominal surgery. The patients were divided into two groups and given 
either 0.5% ropivacaine 3ml or 0.5% bupivacaine in spinal anaesthesia. 
The mean onset of sensory block was 2 minutes in bupivacaine group 
compared to 5 minutes in ropivacaine group. The height of sensory block 
achieved was T5 with bupivacaine compared to T7 with ropivacaine. The 
mean duration of sensory block was 56.5minutes with ropivacaine 
compared to 118 minutes with bupivacaine. The patients in ropivacaine 
group could be mobilized in about 253 minutes in ropivacaine compared 
to 331 minutes in bupivacaine group. There was more incidence of 
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hypotension in bupivacaine group compared to ropivacaine. Thus 
ropivacaine produced shorter duration of spinal blockade with less 
hemodynamic stability. Ropivacaine is an ideal choice for outpatient 
surgeries. 
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MATERIALS AND METHODS 
 This study was a prospective randomized study conducted in Government 
Rajaji Hospital attached to Madurai Medical College.  
 After obtaining Ethical committee approval 60 children taken up for 
elective infraumblical surgeries under spinal anaesthesia were randomly allotted 
into two groups as follows 
 Group B – isobaric Bupivacaine 0.5% 
 Group R – isobaric Ropivacaine 0.5% 
 
Inclusion Criteria 
ASA  I & II patients 
Age: 7 – 12 years 
Both sexes 
Patients undergoing elective infraumblical surgeries. 
Exclusion Criteria 
Bleeding disorder 
Known allergy to Local anaesthetic 
Local site infection 
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Patient refusal 
Patient with neurological deficit 
Written informed consent was obtained from the parents of the patients 
before surgery. Premedication was avoided in these patients in order not to 
confound with the study. A large bore IV line was secured in the operating 
room and started with ringer lactate infusion. The patient was then placed in 
lateral decubitus position and was held firmly by the assistant. With sterile 
precautions, subarachnoid block was performed at L4 – L5 interspace using 
25G Quinckie’s needle. After confirming CSF with aspiration, local anaesthetic 
drug was injected according to the group allotted. The dosage of local 
anaesthetic drug was taken according to the weight of the patient as follows 
 < 5kg  - 0.5mg/kg 
 5 -15kg – 0.4mg/kg 
 >15kg – 0.3mg/kg 
The maximum dose was taken as 20mg 
Parameters recorded: 
1. Hemodynamic parameters: 
a. Pulse rate, non invasive blood pressure and oxygen saturation were 
monitored every 2 minutes for the first 10 minutes, then every 5 
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minutes till first 60 min and every 15 minutes upto 90 minutes or till 
the surgery is over and then in recovery room 
b. Any drop in mean arterial pressure 20% from baseline is taken as 
hypotension and ephedrine 3mg given 
c. Any decrease in pulse rate less than 60/min was treated with atropine 
0.04mg/kg. 
2. Sensory Blockade: 
  Sensory blockade was determined by pin prick along the mid 
axillary line at about a interval of 1 min until the level of block reached 
upto L1. The maximum height of the sensory blockade was noted. 
 Onset of sensory block was defined as the time taken from 
injection of drug to sensory block at L1 and offset of sensory block was 
determined by return of sensation at S5 dermatome. The duration of 
sensory block was determined by the time interval between onset and 
offset of sensory block. 
3. Motor blockade: 
Motor block was determined by the modified Bromage score 
0 -  No motor loss 
1 -  unable to flex hip 
2 – unable to flex knee joint 
3 – unable to flex ankle joint 
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This is assessed at a gap of 1 minute till complete motor blockade 
develops. Onset of motor block was defined as the time taken from 
injection of drug to development of complete motor block (bromage score 
3). Bromage score 0 is taken as complete recovery from motor  block. 
The duration of motor block was determined by the time between onset 
and offset of motor block.  
4. The highest dermatomal level of sensory block was noted. 
5. The Time taken to achieve the highest dermatomal level was noted. 
6.  The Two segment regression time ( ie., the time taken to decrease from 
maximum sensory level  by two segments from initial level ) was noted. 
7. Quality of block was determined as adequate when no sedation or 
analgesia used, inadequate when there is need for additional analgesia, 
and as failed when converted to general anaesthesia. If analgesia was 
inadequate then fentanyl injection 1microgram/kg was given. If the 
regimen was switched to GA then the patient was excluded from the 
study. 
8. Time of micturition was noted. 
9. Duration of surgery was noted. 
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DATA ANALYSIS 
The information collected regarding all the selected cases were recorded in a 
Master Chart. Data analysis was done with the help of computer using 
Epidemiological Information Package (EPI 2010) developed by Centre for 
Disease Control, Atlanta. Using this software range, frequencies, percentages, 
means, standard deviations, chi square and 'p' values were calculated. Kruskul 
Wallis chi-square test was used to test the significance of difference between 
quantitative variables and Yate’s chi square test for qualitative variables.          
A 'p' value less than 0.05 is taken to denote significant relationship. 
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OBSERVATION AND RESULTS 
Table 1: Age distribution 
Group Age in years 
Range Mean SD 
Group B 7-12 8.97 1.33 
Group R 7-12 8.7 1.39 
p - value 0.418  
Not significant 
 
 The mean age are compared and it is found to be statistically not significant 
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Table 2: Sex distribution 
 
Group 
Sex 
Male Female 
No % No % 
Group B 27 90 3 10 
Group R 26 86.7 4 13.3 
p - value 0.5  
Not significant 
 
 
The sex distribution are compared and it is found to be statistically not 
significant 
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Table 3: Height / Weight 
Group Height ( in cms) Weight ( in kgs) 
Mean SD Mean SD 
Group B 110.2 8.3 15.87 2.76 
Group R 108.6 10.6 16.57 2.79 
p - value 0.3248  
Not significant 
0.3476  
Not significant 
 
 
The height and weight are compared and found not to be statistically  significant 
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Table 4: ASA STATUS 
Group ASA 
I II 
No % No % 
Group B 30 100 - - 
Group R 30 100 - - 
 
 
The ASA physical status is compared and found to be statistically not 
significant 
 
 
 
 
 
 
  
 
ASA STATUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30 0
30 0
0% 20% 40% 60% 80% 100%
ASA GRADE
GROUP B
GROUP R
I II
56 
 
 
 
 
Table 5: Onset of sensory block 
Group Onset of sensory block  
( in minutes) 
Range Mean SD 
Group B 4-5 4.6 0.5 
Group R 5-7 6.27 0.64 
p - value 0.0001  
Significant 
 
The onset of sensory block is delayed in ropivacaine group  when compared to 
bupivacaine group and it is found to be statistically significant 
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Table 6: Maximum height of sensory block 
Maximum height of 
sensory block 
Group B Group R 
No % No % 
T4 12 40 - - 
T5 16 53.3 - - 
T6 2 6.7 3 10 
T7 - - 19 63.3 
T8 - - 8 26.7 
Total 30 100 30 100 
 
The average level of maximum sensory block reached in ropivacaine group is 
T7, which is lower than that achieved in bupivacaine group of T5. 
 
 
 
 
  
 
 
Maximum height of sensory block 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12 16 2
00
0 0
3 19 8
0% 20% 40% 60% 80% 100%
GROUP B
GROUP R
T4 T5 T6 T7 T8
58 
 
 
Table 7: Time taken for achieving maximum height of sensory block 
 
Group 
Time taken for achieving 
maximum height of sensory 
block ( in minutes) 
Range Mean SD 
Group B 8-10 8.47 0.57 
Group R 11-14 12.47 0.68 
p - value 0.0001  
Significant 
 
The time taken to achieve the maximum height of sensory block is more in 
ropivacaine group compared to bupivacaine group and it is found to be 
statistically significant. 
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Table 8: Onset of motor block 
Group Onset of motor block 
 ( in minutes) 
Range Mean SD 
Group B 4-5 4.43 0.5 
Group R 8-11 9.13 0.82 
p - value 0.0001 
Significant 
 
The onset of motor block is delayed in ropivacaine group when compared to 
bupivacaine group and it is found to be statistically significant. 
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Table 9: Two segment regression time 
 
Group 
Two segment regression time 
 (in minutes) 
Range Mean SD 
Group B 55-70 63.5 4.2 
Group R 35-50 39.8 4.0 
p - value 0.0001  
Significant 
 
 
The two segment regression time is faster in ropivacaine  group when compared 
to be bupivacaine group and it is found to be stasistically significant 
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Table 10: Duration of sensory block 
 
Group 
Duration of sensory block  
( in minutes) 
Range Mean SD 
Group B 130-160 147.7 8.6 
Group R 100-130 117.7 9.4 
p - value 0.0001  
Significant 
 
The mean duration of sensory block is shorter in ropivacaine group when 
compared to bupivacaine group and it is found to be statistically significant 
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Table 11: Duration of motor block 
 
Group 
Duration of motor block 
 ( in minutes) 
Range Mean SD 
Group B 100-140 118.3 8.7 
Group R 90-120 100 8.3 
p - value 0.0001  
Significant 
 
 
The mean duration of motor block is shorter in ropivacaine group when 
compared to bupivacaine group and it is found to be statistically significant 
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Table 12: Time of micturition 
Group Time of micturition ( in minutes) 
Range Mean SD 
Group B 300-350 317 13.7 
Group R 200-250 214 13.8 
p - value 0.0001  
Significant 
 
The mean time of micturition is shorter in ropivacaine group when compared to 
bupivacaine group and it is found to be statistically significant. 
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Table 13: Duration of surgery 
Group Duration of surgery ( in minutes) 
Range Mean SD 
Group B 40-60 52 5.5 
Group R 30-60 48.5 8.4 
p - value 0.1219  
Not significant 
 
 
The mean duration of surgery is not statistically significant between the 
ropivacaine and bupivacaine group. 
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Table 14: Vasopressor / Atropine 
Group Vasopressor Atropine 
Yes No Yes No 
No % No % No % No % 
Group B 3 10 27 90 - - 30 100 
Group R 2 6.6 28 93.4 - - 30 100 
p - value 0.268 
Not significant 
    
 
There is no statistically significant difference between the groups. 
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Table 15: Adequacy of block 
Adequacy Block Group B Group R 
No % No % 
Adequate 30 100 28 93.3 
Inadequate - - 2 6.7 
p - value 0.2458  
Not significant 
 
 
The adequacy of block is not statistically significant between the ropivacaine 
and bupivacaine group. 
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Table 16: Changes in pulse rate 
Pusle rate  Group B Group R p - 
value 
Significance 
Mean SD Mean SD 
Pre Op. 106.0 12.6 106.2 13.3 0.941 Not significant 
2 minutes 108.3 12.3 110.9 14.2 0.3825 Not significant 
4 minutes 106.2 13.2 110.4 14.3 0.2831 Not significant 
6 minutes 103.5 12.5 105.4 14.3 0.5788 Not significant 
8 minutes 106.8 13.0 106.7 15.2 0.9234 Not significant 
10 minutes 108.3 13.6 110.1 13.7 0.615 Not significant 
15 minutes 109.3 13.2 112.1 14.4 0.4242 Not significant 
20 minutes 110.6 12.7 112.6 14.5 0.5343 Not significant 
25 minutes 110.1 12.2 112.4 14.0 0.4327 Not significant 
30 minutes 110.1 12.0 112.0 13.9 0.5688 Not significant 
35 minutes 110.1 12.1 109.6 12.4 0.9058 Not significant 
40 minutes 109.8 12.8 108.3 12.8 0.5295 Not significant 
45 minutes 109.6 12.6 108.6 13.2 0.823 Not significant 
50 minutes 109.2 13.1 108.9 13.6 0.9058 Not significant 
55 minutes 107.4 12.0 107.9 13.8 0.8186 Not significant 
60 minutes 107.1 11.7 105.6 12.6 0.549 Not significant 
75 minutes 107.4 11.8 106 13.2 0.6359 Not significant 
90 minutes  106.2 11.9 106.6 14.1 0.8591 Not significant 
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Table 17: Changes in SPO2 
SPO2 Group B Group R p - 
value 
Significance 
Mean SD Mean SD 
Pre Op. 99.37 0.72 99.27 0.69 0.5279 Not significant 
2 minutes 100 - 100 - - - 
4 minutes 100 - 100 - - - 
6 minutes 100 - 100 - - - 
8 minutes 100 - 100 - - - 
10 minutes 100 - 100 - - - 
15 minutes 100 - 100 - - - 
20 minutes 100 - 99.97 0.18 0.3173 Not significant 
25 minutes 100 - 99.97 0.18 0.3173 Not significant 
30 minutes 100 - 99.97 0.18 0.3173 Not significant 
35 minutes 100 - 99.97 0.18 0.3173 Not significant 
40 minutes 100 - 99.97 0.18 0.3173 Not significant 
45 minutes 100 - 99.97 0.18 0.3173 Not significant 
50 minutes 100 - 99.8 0.41 0.0605 Not significant 
55 minutes 99.97 0.18 100 - 0.3173 Not significant 
60 minutes 99.93 0.25 99.87 0.35 0.3934 Not significant 
75 minutes 99.83 0.38 99.8 0.41 0.7408 Not significant 
90 minutes  99.73 0.45 99.83 0.38 0.3512 Not significant 
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Table 18: Changes in systolic B.P 
SBP at Group B Group R p - 
value 
Significance 
Mean SD Mean SD 
Pre Op. 98.3 10.5 99.8 11.5 0.7588 Not significant 
2 minutes 98.7 10.4 100.6 11.5 0.6334 Not significant 
4 minutes 97.5 12.3 98.4 12.2 0.8875 Not significant 
6 minutes 94.4 9.6 96 10.6 0.6696 Not significant 
8 minutes 97.5 10.2 98.4 10.9 0.8349 Not significant 
10 minutes 98.7 10.8 100 11.4 0.8342 Not significant 
15 minutes 99.3 10.6 100.3 10.9 0.743 Not significant 
20 minutes 97.8 10.1 99.9 11.0 0.4384 Not significant 
25 minutes 99.6 11.0 100.1 11.5 0.9703 Not significant 
30 minutes 97.9 11.0 99.5 11.3 0.5161 Not significant 
35 minutes 99.2 10.9 100.2 11.0 0.8285 Not significant 
40 minutes 98.9 10.9 100.3 11.0 0.4777 Not significant 
45 minutes 99.2 10.6 100.4 11.2 0.8486 Not significant 
50 minutes 100.1 11.5 100.8 11.4 0.8694 Not significant 
55 minutes 100.0 11.7 101 12.2 0.9641 Not significant 
60 minutes 99.9 0.3 99.8 0.3 0.3934 Not significant 
75 minutes 99.0 10.9 100.6 11.0 0.5065 Not significant 
90 minutes  98.7 10.8 100.1 11.0 0.596 Not significant 
 
 
 
Changes in systolic B.P 
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Table 19: Changes in diastolic B.P 
DBP Group B Group R p - 
value 
Significance 
Mean SD Mean SD 
Pre Op. 66.9 7.7 66.7 8.0 0.6949 Not significant 
2 minutes 66.8 7.9 67.3 8.8 0.9641 Not significant 
4 minutes 64.1 8.1 65.3 9.2 0.84 Not significant 
6 minutes 65.0 6.9 64.9 7.5 0.6598 Not significant 
8 minutes 64.9 7.7 65.9 8.3 0.5952 Not significant 
10 minutes 66.0 8.1 67.0 8.1 0.5708 Not significant 
15 minutes 65.9 7.8 67.1 8.3 0.5728 Not significant 
20 minutes 66.5 7.7 67.3 7.8 0.6282 Not significant 
25 minutes 65.9 13.8 67.2 11.9 0.3526 Not significant 
30 minutes 66.6 8.3 67.4 8.1 0.6287 Not significant 
35 minutes 67.1 8.3 67.6 8.1 0.9044 Not significant 
40 minutes 66.9 7.7 67.4 7.8 0.9821 Not significant 
45 minutes 66.4 7.1 67.2 7.2 0.9127 Not significant 
50 minutes 67.0 7.9 67.5 8.0 0.9224 Not significant 
55 minutes 67.0 6.9 67.5 7.9 0.7749 Not significant 
60 minutes 66.5 8.1 67.3 8.3 0.7889 Not significant 
75 minutes 66.9 8.0 67.5 7.9 0.7748 Not significant 
90 minutes  67.6 8.2 68.0 7.9 0.8747 Not significant 
 
 
 
Changes in diastolic B.P 
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DISCUSSION 
 
Ropivacaine is introduced as an alternative to routinely used bupivacaine 
for surgeries of short duration especially in ambulatory setup. As the intensity 
of motor blockade is less in ropivacaine when compared to bupivacaine it is 
used in labour analgesia and post operative pain relief. The differential blockade 
produced by ropivacaine is an advantage in situations where we want to avoid 
the motor blockade, thereby we can ambulate the patient early in the post 
operative setup. 
Ropivacaine is now available as an isobaric solution. Thus the 
distribution is not affected by gravity and level of blockade would be lesser than 
that of hyperbaric solution. Thus unnecessary high spinal blockade can be 
avoided. This also produces better hemodynamic stability. 
The long duration of motor blockade with bupivacaine may be anxious to 
the parents though hemodynamically stable. Early ambulation of the patients 
relieves the anxiety of the parents and patients themselves. This is more useful 
in cases of surgeries lasting for short duration and patients can be discharged in 
the same day. Thus the drug is fit for ambulatory surgeries. 
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Hence this study was conducted to evaluate the efficacy of isobaric 
ropivacaine and bupivacaine in spinal anaesthesia in children posted for elective 
infraumblical surgeries. 
Onset of sensory block: 
 According to this study, the average time taken for onset of sensory block 
is 6.2 minutes for ropivacaine group and 4.6 minutes for bupivacaine group. 
The lower lipid solubility character of ropivacaine is the cause for delayed onset 
of sensory block when compared to bupivacaine. This result is similar to that 
found in study conducted by V.Gupta, Mehta and colleagues where the onset of 
sensory block is delayed in ropivacaine group when compared to bupivacaine 
group. 
Maximum height of sensory block: 
 According to the study, the maximum height of sensory block was T6 –
T7 in ropivacaine group and T4-T5 in bupivacaine group. The maximum height 
of sensory block is less in ropivacaine group when compared to bupivacaine 
group. As less number of segments is blocked and also the level of block is 
lesser, it avoids cardiovascular and respiratory alterations. This is similar to that 
found in study by Marc Malinovskgy, Charles and Montouvalou and colleagues 
where a higher level of maximum height of sensory block is reached in case of 
bupivacaine group when compared to ropivacaine group. 
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Time taken to reach maximum height of sensory block: 
 According to this study the mean time taken to reach the maximum height 
of sensory block is about 12.4 in ropivacaine group and 8.4 in bupivacaine. The 
average time taken to reach the maximum height is more in case of ropivacaine 
group. This is similar to the study of Malinovsky, Florence Charles where the 
time taken to achieve the maximum height is delayed in case of ropivacaine 
group. 
Two segment regression time 
 According to this study, the mean two segment regression time is about 
39.8 minutes in ropivacaine group compared to that of about 63.5 minutes in 
case of bupivacaine group. This is similar to that of study conducted by 
Mantouvallou and colleagues where the two segment regression time is shorter 
in ropivacaine group. 
Duration of sensory block: 
 According to this study, the mean duration of sensory block is about 117 
minutes in ropivacaine group compared to 147 minutes in case of bupivacaine 
group. Thus the duration of sensory block is less in ropivacaine group. This is 
similar to that of study conducted by Metha and colleagues, Neval Boztuz and 
colleagues, Mantouvalou and colleagues. Early recovery of sensory block in 
case of ropivacaine makes the drug more suitable for ambulatory surgeries. 
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Onset of Motor Block: 
 According to this study, the average time taken for the onset of motor 
block is about 9.1 minutes in case of ropivacaine group compared to 4.4 
minutes in case of bupivacaine group. Thus the onset of motor block is delayed 
in ropivacaine group. This is similar to the study found by Metha and 
colleagues, Neval Boztuz and colleagues, Mantouvalou and colleagues where 
the onset of motor block is delayed in ropivacaine group. 
Duration of motor blockade: 
 According to this study, the mean duration of motor blockade is about 
100 minutes in case of ropivacaine group and 118 minutes in case of 
bupivacaine group. Thus the duration of motor blockade is less in ropivacaine 
group. So the patients can be mobilized early in case of ropivacaine. This 
property makes it ideal for short surgeries and ambulatory surgeries. This is 
similar to study conducted by those of Metha and colleagues, Neval Boztuz and 
colleagues, Mantouvalou and colleagues where the duration of motor blockade 
is shorter in case of ropivacaine group. 
Time taken for micturition: 
 According to this study, the mean time taken for micturition was about 
214 minutes in case of ropivacaine group compared to about 317 minutes in 
case of bupivacaine group. This is similar to that study conducted by Neval 
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Boztuz and Zekiye and colleagues where the mean time of micturition is less in 
ropivacaine group. As the patient micturates earlier in case of ropivacaine, the 
patient meets the discharge criteria earlier. Thus ropivacaine is more useful in 
ambulatory surgeries. 
Quality of Block: 
 According to this study, quality of block was adequate in both groups. 
This is similar to that of study conducted by McChelland and colleagues where 
the quality of block is adequate in both groups. Thus ropivacaine can be used as 
an alternative drug to bupivacaine in spinal anaesthesia. 
Hemodynamic parameters: 
a. Pulse rate : 
According to the study, there is no significant difference between the 
drop in pulse rate between both groups. 
b. Blood Pressure: 
According to the study, there is no significant difference between the 
drop in blood pressure between both groups. 
c. Oxygen saturation: 
According to the study, there is no significant difference between both 
groups as the saturation was maintained through out the surgery. 
76 
 
Thus ropivacaine proves to be good alternative to bupivacaine in case of 
infraumblical surgeries. Ropivacaine is more suitable for shorter duration of 
surgeries. 
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SUMMARY 
 This is a randomized controlled study involving 60 cases of children of 
age between 7 and 12 years posted for elective infraumblical surgeries under 
spinal anaeshesia. They are allotted into two groups, Group R receiving 0.5% 
ropivacaine and Group B receiving 0.5% bupivcaine. The following parameters 
are noted in the study periods. The  onset of sensory block, maximum height of 
sensory block, time taken to reach the maximum height of sensory block, two 
segment regression time, onset of motor block, mean duration of sensory & 
motor block and quality of block. The hemodynamic parameters noted are pulse 
rate, systolic and diastolic blood pressure, oxygen saturation with pulse 
oximeters. The use of atropine and vasopressors are noted. Any complications 
during the study are also noted. 
 According to the study, there was significant delay in onset of sensory 
and motor block in ropivacaine group. There was earlier two segment regression 
time in ropivacaine group. There was earlier offset of sensory and motor block 
and time taken for micturition was earlier in ropivacaine group. The quality of 
block was adequate in both groups. The hemodynamic parameters were well 
maintained in both groups.  
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 Thus ropivacaine provides a good alternative to bupivacaine in case of 
short duration of surgeries. It is more suitable in cases of ambulatory surgeries 
where the patients meet the discharge criteria earlier and can be discharged from 
the hospital. 
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CONCLUSION 
 Ropivacaine used for spinal anaesthesia in children has delayed onset of 
sensory and motor block.  It also has faster offset of sensory and motor block 
with adequate quality of block compared to that of bupivacaine. 
 It is concluded that Ropivacaine can be used as a good alternative to 
Bupivacaine in case of shorter duration of surgeries especially in ambulatory 
setup. 
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STUDY PROFORMA 
Name  :      Date : 
Age  :      Sex : 
IP No. :      Ht :  Wt: 
ASA  :       
Diagnosis :      Surgery: 
Drug  : 
Premedication:       Posture 
Spinal Needle Gauge:      Interspace:  
           
Onset 
of 
sensory 
block 
Max. 
Height 
Of 
sensory 
block 
Time 
to  
Reach 
max. 
height 
Onset 
of 
motor 
block 
Time of 
two 
segment 
regression 
Offset 
of 
sensory 
block at 
S5 
Duration 
of motor 
block 
Time of 
micturit
ion 
        
 
Hemodynamics 
Time Heart rate NIBP SPO2 Vasopressor  Atropine 
Pre op      
2 min      
4 min      
6 min      
8 min      
10 min      
15 min      
20 min      
25 min      
30 min      
35 min      
40 min      
86 
 
45 min      
50 min      
55 min      
60 min      
75 min      
90 min      
 
Duration of Surgery  : 
Duration of sensory block : 
Duration of Motor block  : 
Quality of Block   : 
Time of Micturition  : 
If Ephedrine used, Dose  : 
If Atropine used, Dose  : 
Other complication  : 
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1 Suryaprakash 43515 R inguinal hernia R 7 M 105 15 1 7 T8 12 10 45 120 110 250 30 NO NO adq
2 surendar 58147 urethroplasty R 10 M 115 18 1 6 T7 14 9 50 120 100 240 40 NO NO adq
3 Dhanalakshm 48980 cystoscopy R 8 F 100 14 1 6 T8 13 8 40 100 90 200 30 NO NO adq
4 subash 58637 L inguinal hernia R 10 M 120 21 1 5 T7 14 10 40 110 90 230 40 NO NO adq
5 Alaguraja 58092 L inguinal hernia R 10 M 124 21 1 6 T6 12 9 45 120 100 240 50 NO NO adq
6 Mohanraj 60896 appendicectomy R 12 F 120 20 1 5 T7 11 10 40 130 100 230 55 NO NO adq
7 Vignesh 60116 cystoscopy R 8 M 96 14 1 6 T7 13 9 45 130 110 220 50 NO NO adq
8 karthick 63042 R inguinal hernia R 9 M 112 17 1 5 T8 12 11 40 110 90 210 40 NO NO adq
9 Kamlesh 60904 R inguinal hernia R 7 M 104 15 1 6 T7 12 11 35 130 110 220 60 NO NO adq
10 syed ismail 67736 L inguinal hernia R 9 M 110 18 1 7 T7 13 9 35 120 100 220 60 YES NO adq
11 Karuppasama 61009 appendicectomy R 11 M 130 21 1 6 T7 12 10 40 120 110 230 50 NO NO in adq
12 Balamurugan 42112 R inguinal hernia R 9 M 106 17 1 6 T7 12 9 40 110 90 200 50 NO NO adq
13 Anadraj 42633 L inguinal hernia R 8 M 100 14 1 6 T8 13 9 35 100 90 210 40 NO NO adq
14 Praveenraj 44329 gatronemius bursa R 8 M 102 14 1 6 T7 13 8 40 110 90 210 40 NO NO adq
15 Mohammed 44326 L inguinal hernia R 7 M 98 13 1 7 T6 12 9 35 110 100 220 40 YES NO adq
16 Harikumar 44324 L inguinal hernia R 10 M 126 20 1 7 T7 12 9 35 130 100 220 50 NO NO in adq
17 susaipraveen 44316 urethroplasty R 9 M 105 16 1 7 T7 12 10 45 110 90 200 50 NO NO adq
18 arun 44856 R inguinal hernia R 9 M 108 17 1 6 T8 13 8 40 120 100 200 55 NO NO adq
19 Mohanapriya 43736 colostmoy closure R 8 F 100 14 1 6 T7 12 9 35 110 100 210 50 NO NO adq
20 sundarapandi 46974 R inguinal hernia R 8 M 108 16 1 6 T7 13 9 40 120 110 210 55 NO NO adq
21 anandan 18707 R inguinal hernia R 7 M 100 14 1 6 T7 12 9 40 130 110 210 50 NO NO adq
22 sudhakar 14457 L inguinal hernia R 9 M 110 18 1 7 T6 12 8 45 130 120 200 55 NO NO adq
23 vinothkumar 17558 L inguinal hernia R 11 M 130 22 1 7 T7 13 9 35 130 110 210 60 NO NO adq
24 suresh 44782 R inguinal hernia R 10 M 124 20 1 6 T8 12 9 40 110 90 200 60 NO NO adq
25 durairaj 4738 R inguinal hernia R 7 M 96 14 1 6 T7 12 10 40 110 100 210 50 NO NO adq
26 veeralagu 57576 R inguinal hernia R 7 M 98 14 1 7 T8 13 9 45 110 90 200 50 NO NO adq
27 ramesh 508111 orchidopexy R 8 M 102 15 1 7 T7 12 9 40 120 100 210 40 NO NO adq
28 pandeeswaran 1880 R inguinal hernia R 8 M 100 14 1 7 T8 13 8 40 110 100 200 45 NO NO adq
29 janani 41006 appendicectomy R 10 F 114 18 1 7 T7 13 9 35 130 100 210 60 NO NO adq
30 ammer 75421 R inguinal hernia R 7 M 95 13 1 6 T7 12 8 35 120 100 200 50 NO NO adq
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31 arun 50498 L inguinal hernia B 9 M 110 17 1 4 T6 10 4 70 150 140 350 40 NO NO adq
32 Veeramani 73453 L inguinal hernia B 9 M 108 16 1 5 T5 9 5 70 160 130 340 50 NO NO adq
33 surendar 75690 R inguinal hernia B 7 M 95 13 1 4 T5 8 4 60 150 120 300 55 NO NO adq
34 ajaynarayanan 75692 appendicectomy B 10 M 118 19 1 4 T4 8 5 65 160 120 320 60 NO NO adq
35 ajithkumar 82913 R inguinal hernia B 10 M 116 18 1 5 T4 9 5 60 160 130 320 55 YES NO adq
36 arunkumar 75692 L inguinal hernia B 9 M 112 17 1 5 T5 9 4 60 150 130 340 60 NO NO adq
37 santhosh 16375 L inguinal hernia B 8 M 108 15 1 4 T5 9 5 70 150 120 310 55 NO NO adq
38 baskar 16932 appendicectomy B 9 M 114 16 1 5 T5 8 4 65 140 110 300 50 NO NO adq
39 Alaguraja 23739 appendicectomy B 12 F 122 22 1 5 T4 8 4 70 160 110 310 60 NO NO adq
40 Suryaprakash 43515 R inguinal hernia B 7 M 94 12 1 4 T4 9 4 60 130 110 300 50 NO NO adq
41 vigneshkumar 44860 R inguinal hernia B 8 M 106 14 1 4 T5 8 5 60 140 110 310 60 NO NO adq
42 sameen 44876 R inguinal hernia B 8 M 108 14 1 4 T4 8 4 60 150 100 300 50 NO NO adq
43 arjun 60905 L inguinal hernia B 9 M 116 18 1 5 T4 9 4 60 140 110 320 50 NO NO adq
44 Alagu 80080 R inguinal hernia B 9 M 114 18 1 5 T5 8 5 65 140 120 310 45 NO NO adq
45 vigneshwarn 61977 appendicectomy B 11 M 122 21 1 5 T5 8 4 65 160 120 320 45 YES NO adq
46 santhosh 14572 R inguinal hernia B 8 M 104 13 1 4 T5 9 4 60 140 110 320 40 NO NO adq
47 sirajudheen 47080 meatal stenosis B 10 M 116 17 1 4 T4 8 5 65 150 120 330 55 NO NO adq
48 selvakumar 48165 R inguinal hernia B 10 M 118 18 1 4 T5 8 4 65 160 120 310 50 NO NO adq
49 sikkandahar b 47703 urethroplasty B 8 M 102 13 1 5 T4 8 5 55 140 110 300 50 NO NO adq
50 ilavarasan 49295 L inguinal hernia B 9 M 114 17 1 5 T5 9 5 60 140 120 300 50 NO NO adq
51 karthick 49286 orchidopexy B 7 M 95 12 1 5 T4 8 5 60 140 110 310 50 NO NO adq
52 alakar 49700 orchidopexy B 9 M 115 17 1 5 T5 8 4 65 150 130 310 50 NO NO adq
53 selvam 4757 R inguinal hernia B 11 M 120 20 1 4 T4 9 4 70 160 120 330 60 NO NO adq
54 raghunathan 45028 stricture urethera B 10 M 116 16 1 5 T6 9 4 65 150 110 320 50 YES NO adq
55 Balamurugan 50328 R inguinal hernia B 8 M 104 13 1 5 T5 8 5 65 140 120 320 55 NO NO adq
56 Balaguru 50818 R inguinal hernia B 8 M 106 14 1 5 T5 9 4 60 140 110 310 50 NO NO adq
57 Manikandan 51283 R inguinal hernia B 7 M 96 12 1 5 T4 8 4 60 140 120 320 55 NO NO adq
58 Priyadarshini 42135 cystoscopy B 10 F 118 17 1 4 T4 8 5 65 150 130 330 50 NO NO adq
59 ramya 52073 hematoma vulva B 11 F 116 15 1 5 T5 8 4 70 150 120 340 60 NO NO adq
60 akash 52812 urethroplasty B 8 M 102 12 1 5 T5 9 5 60 140 120 310 50 NO NO adq
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1 110 120 124 130 122 126 128 130 128 124 120 116 118 126 118 112 110 112 99 100 100 100 100 100 100 100 99 99 100 100 100 99 100 100 99 100
2 96 110 118 120 114 98 96 114 112 114 108 102 100 96 98 98 97 95 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
3 124 130 126 108 104 102 130 132 135 136 127 117 116 118 124 115 122 126 98 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
4 94 98 94 88 86 102 111 105 103 99 95 96 96 98 99 94 92 90 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100
5 92 94 94 86 88 101 98 94 96 95 92 90 90 88 91 89 93 90 100 100 100 100 100 100 100 99 100 100 100 100 100 99 100 100 100 100
6 88 95 90 86 85 92 96 99 95 93 91 90 91 86 88 88 88 92 99 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 100
7 116 124 129 115 118 123 128 124 126 127 119 125 121 123 127 119 123 120 99 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 99 100
8 118 125 130 120 124 125 130 130 121 122 119 118 120 121 117 119 123 120 98 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100
9 125 130 131 122 129 125 121 126 130 124 122 120 123 127 123 119 121 125 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 100 100 100
10 102 108 114 102 102 112 107 104 105 103 108 103 101 100 101 104 102 104 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
11 92 96 98 89 88 92 91 94 93 99 101 95 96 97 91 94 90 90 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
12 108 110 106 100 107 111 109 112 114 117 112 109 106 105 104 110 113 108 99 100 100 100 100 100 100 100 100 100 100 99 99 99 100 100 100 100
13 121 126 115 117 121 122 127 128 123 127 121 122 124 126 120 120 117 116 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
14 116 119 108 109 116 115 119 121 125 119 118 116 114 112 110 111 117 115 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 99 100 100
15 123 124 125 119 116 120 124 126 121 126 124 122 125 127 129 121 122 124 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
16 89 88 94 87 92 91 95 94 99 101 95 93 95 97 99 93 92 90 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100
17 92 96 99 98 95 99 98 93 100 96 99 95 97 99 94 92 90 91 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 99
18 99 101 95 94 95 96 97 99 111 113 99 96 94 95 93 90 93 95 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
19 112 118 120 110 116 119 115 119 121 117 113 118 119 120 115 112 114 114 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100
20 118 122 116 112 120 122 118 116 115 113 108 112 118 117 119 111 107 108 98 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 99
21 120 127 124 120 126 128 129 126 128 130 131 127 125 123 125 121 122 126 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
22 105 103 110 104 103 109 111 114 107 106 103 105 107 108 107 103 101 102 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100
23 85 88 89 81 80 88 92 91 85 83 88 85 88 89 90 91 93 88 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
24 90 94 100 92 96 97 99 101 96 95 97 93 90 96 90 88 89 86 99 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 100 99
25 115 119 121 114 119 124 122 120 121 117 120 118 114 116 113 112 112 115 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100
26 117 124 118 122 126 129 130 131 123 128 122 126 125 127 124 120 120 124 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
27 105 109 100 106 104 108 109 110 113 109 107 104 106 110 109 111 106 107 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
28 104 110 102 102 106 110 117 105 104 105 109 111 109 107 105 102 104 108 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100
29 86 89 88 84 80 88 85 87 89 93 95 99 98 92 88 84 85 89 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
30 125 130 133 126 122 130 131 134 133 129 126 125 122 122 127 125 122 127 98 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
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31 106 104 100 108 103 101 98 105 105 109 104 105 104 103 104 105 103 108 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100
32 102 105 101 98 105 103 106 110 111 106 104 104 106 108 103 105 105 106 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
33 126 130 121 120 131 132 129 122 128 130 132 136 134 130 127 125 128 124 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
34 84 88 87 82 81 88 92 94 93 97 99 100 97 93 89 85 86 88 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
35 92 96 94 88 94 95 93 96 99 101 102 96 94 95 97 95 99 94 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
36 108 112 114 105 102 109 112 116 109 105 106 104 102 103 107 105 106 104 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
37 115 117 110 110 119 121 118 112 116 113 117 119 120 121 119 115 112 117 98 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
38 107 106 110 104 105 103 109 112 115 117 110 114 116 117 111 107 109 105 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
39 86 88 85 81 88 89 93 96 95 90 88 87 88 85 89 91 93 89 100 100 100 100 100 100 100 100 100 100 100 100 99 100 100 100 99 100
40 125 127 130 123 128 129 132 127 125 126 122 126 126 128 124 122 120 122 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
41 115 118 120 114 113 120 122 125 121 118 123 122 122 121 120 122 125 119 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
42 111 118 112 110 117 118 121 119 116 115 120 121 120 117 118 116 112 110 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
43 104 108 100 103 109 112 106 109 110 113 115 119 117 113 116 118 111 107 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100
44 108 107 101 100 109 111 107 109 115 117 111 107 106 105 107 109 106 104 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
45 90 93 88 89 94 96 99 97 94 99 101 97 96 99 95 94 98 94 99 100 100 100 100 100 100 100 100 100 100 100 99 100 100 99 100 99
46 118 119 120 117 119 115 114 118 120 122 125 120 120 121 117 116 118 114 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
47 96 99 101 95 97 95 98 99 101 96 95 97 96 94 93 95 91 94 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100 99
48 92 96 100 94 99 94 94 97 95 98 100 97 98 96 92 95 94 96 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
49 117 110 115 117 114 113 118 120 121 119 116 118 117 115 117 119 116 112 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100
50 106 108 100 107 110 113 109 108 105 108 106 107 108 108 105 104 107 105 98 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
51 124 122 128 120 122 126 128 130 127 126 125 129 125 121 117 118 120 122 98 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
52 102 104 98 104 109 110 103 104 107 106 108 107 106 110 105 104 106 103 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
53 93 92 88 85 90 94 96 97 94 96 98 99 100 100 101 96 95 97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
54 100 102 97 99 101 94 95 93 94 99 100 97 98 99 96 95 98 94 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
55 117 119 110 112 116 120 121 122 117 116 119 114 112 113 111 116 118 110 99 100 100 100 100 100 100 100 100 100 100 100 99 100 99 100 100 100
56 112 114 107 102 110 115 116 120 122 116 118 119 118 121 117 115 112 119 98 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
57 122 127 128 120 122 127 130 133 128 129 127 124 122 128 122 120 125 125 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
58 92 99 100 93 91 90 99 101 95 96 93 98 96 99 94 97 95 94 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99 100
59 89 93 92 86 85 90 91 93 96 92 91 88 86 84 87 88 90 85 99 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
60 122 127 128 120 122 127 130 133 128 129 127 124 120 128 122 120 125 125 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
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1 90 88 88 90 94 90 92 90 90 90 94 92 94 94 90 90 90 90 60 56 54 56 58 60 60 62 58 62 64 60 62 60 62 60 62 64
2 110 112 104 108 110 114 110 114 112 112 110 110 112 116 114 112 110 110 70 74 76 74 74 76 70 70 72 72 76 70 70 70 70 70 70 72
3 90 90 88 86 90 84 88 90 90 88 86 88 88 90 90 90 90 90 60 60 54 58 56 58 60 62 60 60 60 62 62 60 62 60 60 60
4 116 118 114 110 112 116 112 112 114 110 114 114 110 112 114 114 112 112 74 76 76 74 72 74 74 72 74 72 76 76 74 74 74 74 74 74
5 114 118 114 116 112 112 114 116 110 112 116 114 114 114 114 112 114 114 70 74 72 72 70 72 70 70 70 74 74 72 72 72 70 74 74 72
6 120 114 120 110 116 122 124 120 124 120 120 120 122 124 126 122 120 120 84 80 82 80 80 84 84 84 82 82 84 84 84 84 84 82 84 84
7 90 88 84 80 86 88 92 90 90 88 90 90 90 92 88 86 88 90 60 60 56 56 60 60 60 62 60 58 60 58 58 58 60 60 60 60
8 92 94 90 88 92 94 96 92 92 90 92 90 90 90 90 92 94 92 64 64 60 60 58 60 60 62 62 60 60 64 64 64 62 62 64 62
9 88 90 84 88 90 92 88 88 88 86 88 90 90 90 92 92 90 88 60 58 56 58 60 60 60 58 58 58 58 58 60 60 62 60 60 60
10 92 94 92 90 94 94 94 92 96 92 92 92 94 94 94 92 92 94 64 66 64 64 62 60 60 62 62 62 64 64 62 62 64 62 60 62
11 122 124 120 116 118 120 124 122 124 122 120 120 120 120 124 126 122 122 84 80 84 76 80 80 80 82 82 84 85 88 88 88 88 90 88 86
12 94 96 92 90 88 92 94 94 92 92 94 92 92 90 90 94 92 94 62 64 60 60 62 62 60 62 60 64 62 64 62 62 60 60 60 64
13 96 96 90 92 94 94 96 96 92 92 90 92 92 92 90 94 96 96 62 60 60 58 64 64 64 62 64 64 62 62 62 62 64 64 64 66
14 92 92 90 88 94 94 96 94 94 94 94 96 96 90 94 94 94 94 64 60 58 58 60 62 62 64 64 64 64 62 64 64 64 62 62 62
15 90 92 88 85 90 92 92 90 94 92 92 94 94 94 92 92 90 90 60 58 58 60 62 62 62 64 64 62 60 60 60 62 60 60 60 60
16 114 118 120 112 114 114 112 110 114 114 114 112 116 118 120 118 116 116 78 80 74 74 76 78 78 76 18 80 80 74 76 78 76 78 76 78
17 108 108 110 102 100 104 104 104 108 110 108 106 104 104 108 108 110 106 74 78 70 76 78 80 82 78 78 76 76 74 76 76 76 76 74 76
18 110 110 104 100 102 106 106 106 102 104 104 106 106 104 106 106 104 102 74 76 70 70 76 76 76 76 78 74 74 74 74 74 76 76 76 78
19 92 94 88 90 88 92 94 92 94 94 96 90 90 92 94 92 94 90 64 66 60 60 62 64 60 60 60 62 62 64 64 64 64 62 64 64
20 94 98 90 88 90 94 96 96 96 94 92 94 94 94 94 94 97 96 62 66 60 58 64 64 64 62 62 62 64 64 64 64 62 62 62 64
21 90 88 86 92 94 94 94 92 90 90 90 90 92 92 92 94 96 94 58 56 56 58 54 60 60 62 60 60 60 62 62 62 60 62 60 60
22 108 110 106 100 106 106 104 104 102 102 104 104 104 106 106 108 106 104 76 78 78 70 70 76 78 78 78 80 74 74 74 74 74 76 74 76
23 114 110 116 108 114 114 112 112 115 116 116 120 120 118 118 116 118 116 76 80 76 74 76 70 76 78 76 76 76 74 74 76 76 74 76 74
24 106 106 108 100 106 108 108 106 110 106 110 112 112 110 108 108 106 106 72 74 68 72 74 74 72 74 72 72 72 74 74 74 74 76 76 78
25 88 90 88 86 90 90 90 90 88 90 92 90 90 90 90 90 92 90 60 58 58 60 62 60 60 62 62 62 60 60 60 60 60 60 62 64
26 90 92 88 86 84 88 88 90 90 92 92 94 94 96 94 92 92 92 58 60 60 58 54 58 58 58 58 60 60 60 60 60 60 62 62 62
27 92 92 94 90 88 90 92 92 92 94 94 94 94 94 94 94 92 92 60 60 60 62 58 62 64 62 62 62 64 64 62 62 62 62 64 64
28 90 90 94 88 92 94 92 92 92 92 94 94 96 96 94 94 94 92 60 60 60 60 62 60 62 60 60 62 64 62 62 64 64 62 62 62
29 114 116 110 110 116 118 116 120 118 118 116 114 112 116 118 116 116 118 74 78 80 70 76 74 76 74 76 76 72 76 74 74 74 72 72 72
30 88 90 92 90 88 90 90 92 90 90 92 94 92 92 92 92 90 92 58 60 60 62 58 60 60 62 64 60 60 62 60 60 60 60 62 60
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31 94 94 92 90 92 94 94 92 96 92 92 92 94 94 94 92 92 94 64 66 64 64 62 62 60 62 62 62 64 62 62 62 64 62 60 64
32 92 94 88 90 88 92 94 92 94 92 96 90 92 92 94 92 94 92 64 66 60 62 62 64 60 60 62 62 62 66 64 64 64 62 64 62
33 90 92 88 85 90 92 92 90 96 92 92 94 92 92 92 92 90 90 60 60 58 60 62 62 60 64 64 62 60 58 60 62 60 60 60 62
34 106 106 108 100 106 106 108 106 108 106 110 112 112 110 106 108 106 106 72 72 68 72 74 74 72 74 72 72 72 74 74 74 74 76 76 78
35 108 106 110 100 106 108 108 104 110 106 110 108 110 110 108 108 108 108 76 74 66 72 70 74 76 76 74 78 76 76 74 74 72 72 74 78
36 92 94 90 90 94 94 94 94 96 92 94 96 94 94 94 96 92 94 66 64 64 62 62 60 60 64 62 62 62 64 62 62 64 62 60 62
37 90 90 92 88 94 94 96 92 92 94 96 94 92 92 94 96 94 92 60 60 62 64 62 60 62 62 60 62 66 62 62 62 64 62 62 64
38 100 96 90 92 92 96 96 94 92 90 92 92 94 96 96 100 94 96 68 64 62 60 58 60 64 62 62 66 60 64 64 66 62 62 66 64
39 120 114 120 110 116 122 124 120 124 120 120 120 122 124 126 122 120 120 84 80 82 80 80 84 84 84 82 82 84 84 84 84 84 82 84 84
40 88 90 84 88 90 92 88 88 88 86 88 90 90 90 92 92 90 88 60 58 56 58 60 60 60 58 58 58 58 58 60 60 62 60 60 60
41 92 92 94 90 88 90 92 92 92 94 94 94 94 94 94 94 92 92 60 60 60 62 58 62 64 62 62 62 64 64 62 62 62 62 64 64
42 90 90 94 88 92 94 92 92 92 92 94 94 94 96 94 94 94 92 60 60 60 60 62 60 62 60 60 62 64 62 62 64 64 62 62 62
43 94 94 92 90 92 94 94 92 96 92 92 92 92 94 94 92 92 94 64 66 64 64 62 62 60 62 62 62 64 62 62 62 64 62 60 64
44 92 94 88 90 88 92 94 92 94 92 96 90 92 92 94 92 94 92 64 66 60 62 62 64 60 60 62 62 62 66 64 64 64 62 64 62
45 114 110 116 108 114 114 112 112 115 116 116 120 118 118 118 116 118 116 76 80 76 74 76 70 76 78 76 76 76 74 74 76 76 74 76 74
46 92 92 94 90 88 90 92 92 92 94 94 94 94 94 94 94 92 92 60 60 60 62 58 62 64 62 62 62 64 64 62 62 62 62 64 64
47 106 106 108 100 106 106 108 106 108 106 110 112 112 110 106 108 106 106 72 72 68 72 74 74 72 74 72 72 72 74 74 74 74 76 76 78
48 108 106 110 100 106 108 108 104 110 106 110 108 110 110 108 108 108 108 76 74 66 72 70 74 76 76 74 78 76 76 76 74 72 72 74 78
49 90 90 88 86 90 84 88 90 90 88 86 88 88 90 90 90 90 90 60 60 54 58 56 58 60 62 60 60 60 62 60 60 62 60 60 60
50 92 94 90 88 92 94 96 92 92 90 92 90 90 90 90 92 94 92 64 64 60 60 58 60 60 62 62 60 60 64 64 64 62 62 64 62
51 90 88 88 90 94 90 92 90 90 90 94 92 92 94 90 90 90 90 60 56 54 56 58 60 60 62 58 62 64 60 60 60 62 60 62 64
52 92 94 90 88 92 94 96 92 92 90 92 90 90 90 90 92 94 92 64 64 60 60 58 60 60 62 62 60 60 64 64 64 62 62 64 62
53 120 124 120 116 118 120 126 122 124 122 122 120 120 120 124 126 124 122 84 80 84 76 80 84 80 82 82 84 86 88 88 88 84 90 88 86
54 114 118 120 112 114 114 112 110 114 114 114 112 116 118 120 118 116 116 78 80 74 74 76 78 78 76 18 80 80 74 76 78 76 78 76 78
55 90 90 88 86 90 84 88 90 90 88 86 88 88 90 90 90 90 90 60 60 54 58 56 58 60 62 60 60 60 62 62 60 62 60 60 60
56 90 88 84 80 86 88 92 90 90 88 90 90 92 92 88 86 88 90 60 60 56 56 60 60 60 62 60 58 60 58 58 58 60 60 60 60
57 88 90 84 88 90 92 88 88 88 86 88 90 90 90 92 92 90 88 60 58 56 58 60 60 60 58 58 58 58 58 58 60 62 60 60 60
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